Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02677961 · ClinicalTrials.gov registry record

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

A clinical trial of Neoplasms, Connective and Soft Tissue and Bone Neoplasms, sponsored by Ohio State University Comprehensive Cancer Center.

Recruiting
Registry status
1,500
Enrollment target
1
Study location

NCT02677961 is a study of Neoplasms, Connective and Soft Tissue and Bone Neoplasms that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 1,500 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02677961, a study of Neoplasms, Connective and Soft Tissue and Bone Neoplasms, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.

RECRUITING
Registry status
1,500 participants
Enrollment target
1
Study location

Study Summary

Translational studies in cancer research can be impeded by the lack of high-quality clinical data that can be correlated with research questions. This is particularly true in the case of rare diseases, such as bone and soft tissue tumors. It is therefore the purpose of this study to create a prospective EHR-based clinical registry for individuals with bone and soft-tissue tumors.

Interventions

  • OTHER Observation

Study Locations (1)

Ohio

  • Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2015-07-01
Est. Completion 2027-12-31

What the Registry Record Tells You About NCT02677961

The ClinicalTrials.gov registry entry for NCT02677961 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Neoplasms, Connective and Soft Tissue appearing as the primary indexed condition, and to 1 intervention - of which Observation is the first listed.

NCT02677961 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02677961 about?

NCT02677961 is a clinical study titled "An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry". Translational studies in cancer research can be impeded by the lack of high-quality clinical data that can be correlated with research questions. This is particularly true in the case of rare diseases, such as bone and soft tissue tumors. It is therefore the purpose of this study to create a prospec...

What is the current status of trial NCT02677961?

This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2015-07-01. Estimated completion is 2027-12-31.

What conditions does trial NCT02677961 study?

This clinical trial studies the following conditions: Neoplasms, Connective and Soft Tissue, Bone Neoplasms.

What interventions are being tested in trial NCT02677961?

The interventions under investigation include: Observation (OTHER).

Who is sponsoring clinical trial NCT02677961?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02677961 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.